Lipophilic statins antagonistically alter the major epithelial‐to‐mesenchymal transition signaling pathways in breast cancer stem–like cells via inhibition of the mevalonate pathway-Reference-Cited by-同舟云学术

Lipophilic statins antagonistically alter the major epithelial‐to‐mesenchymal transition signaling pathways in breast cancer stem–like cells via inhibition of the mevalonate pathway

Published:2018-09-06 Issue:2 Volume:120 Page:2515-2531
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Koohestanimobarhan Soheila¹,Salami Siamak¹^ORCID,Imeni Vahideh¹,Mohammadi Zeinab¹,Bayat Omid¹

Affiliation:

1. Cell Death and Differentiation Signaling Research Lab, Clinical Biochemistry Department, School of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

Funder

Shahid Beheshti University of Medical Sciences

Iran National Science Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27544

Reference50 articles.

1. The changing global patterns of female breast cancer incidence and mortality;Bray F;Childhood,2004

2. Treating Breast Cancer in the 21st Century: Emerging Biological Therapies